HomeTELO • NASDAQ
add
Telomir Pharmaceuticals Inc
Previous close
$6.83
Day range
$6.42 - $6.84
Year range
$4.76 - $20.72
Market cap
195.28M USD
Avg Volume
47.77K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 1.08M | 121.44% |
Net income | -9.33M | -1,814.86% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.23K | -13.25% |
Total assets | 4.77M | 9,696.36% |
Total liabilities | 1.34M | 35.45% |
Total equity | 3.44M | — |
Shares outstanding | 29.61M | — |
Price to book | 56.88 | — |
Return on assets | -53.44% | — |
Return on capital | -60.76% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -9.33M | -1,814.86% |
Cash from operations | -1.09M | -325.04% |
Cash from investing | — | — |
Cash from financing | 1.09M | 332.87% |
Net change in cash | -1.22K | 75.14% |
Free cash flow | -409.02K | — |
About
Founded
2021
Headquarters
Website
Employees
1